Ramiro Sanchez, Jr., MD

Sanchez, Ramiro 3685793_30556605 TP.jpg

Title: Vice President
Company: Otsuka America Pharmaceutical, Inc.
Location: New Hope, Pennsylvania, United States

Ramiro Sanchez, Jr., MD, Vice President of Otsuka America Pharmaceutical, Inc., has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in developing new therapies for patients.

When starting out in his career, Dr. Sanchez saw his work as most valuable in the academic sector. He spent a year instructing psychiatry at Yale University before realizing he could help more people on a bigger scale with a slight career change. After leaving Yale, he started working for Purdue Pharma as an associate medical director. From there, he garnered managerial and executive experience through various positions with the Bristol-Myers Squibb Company. In 2007, he joined Otsuka America Pharmaceuticals as the senior director of Global Clinical Development. In 2010, he was named a vice president of the company and in 2013, Dr. Sanchez was chosen for his current position as Senior Vice President of Global Clinical Development. For him, the moment that stands out knowing he made such a difference in people’s live with his work was seeing the psychiatric treatment drug Abilify on the shelf of a CVS pharmacy. Dr. Sanchez played a role in bringing that medication to patients.

Fascinated by the machinations of the human mind from an early age, Dr. Sanchez pursued this nascent interest by first earning an AB from Northwestern University in 1984. He continued with a post-baccalaureate fellowship in sleep disorders medicine at Harvard Medical School. He continued with an internship at the National Institutes of Mental Health Research before earning an MD from Northwestern University. He followed this degree with an internship, residency and fellowship in medicine, neurology and psychiatry at the Yale School of Medicine. Since 1999, he has served as a trustee on the board of directors of the Connecticut Mental Health Foundation at Yale University. Furthermore, he has consulted for the Connecticut Science Fair Association, Inc. since 1996.

Dr. Sanchez’s achievements include procuring patents for pharmaceuticals. He was the first to Malcolm Bowers Clinical Rounds at the Yale School of Medicine. Additionally, he has contributed to research in sleep science, light treatment and biological rhythms. For his work, Dr. Sanchez has received a number of accolades and recognition, including 2016’s Leadership Award from the International Society for CNS Drug Development. In 2015, he was honored with Otsuka President’s Award for Rexulti Dual-Indication Approval. He has received several STAR Awards from Bristol-Myers Squibb Company, as well as grant research awards and scholarships. In his career, he has maintained professional affiliation with a variety of organizations including the Royal Society of Medicine, the International Society for CNS Drug Development, the American Psychiatric Association and The Sleep Research Society.

For more information, please visit:

Pharm Exec’s Emerging Pharma Leaders 2018

Pharm Exec’s Emerging Pharma Leaders 2018: Dr. Sanchez’s Feature 

Industry Leaders Profile 

Press Release 

Lifetime Achievement 

Contact Dr. Sanchez:

Leave a Reply